Phibro Animal Health Corporation
PAHC
$38.25
-$0.33-0.86%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 21.71M | 24.02M | 27.46M | 26.53M | 17.22M |
| Total Depreciation and Amortization | 11.82M | 12.45M | 12.89M | 12.83M | 10.99M |
| Total Amortization of Deferred Charges | 2.12M | 572.00K | 572.00K | 572.00K | 1.99M |
| Total Other Non-Cash Items | -1.80M | 5.87M | 3.52M | 2.91M | 5.32M |
| Change in Net Operating Assets | -9.76M | -26.71M | -25.09M | -33.54M | -14.25M |
| Cash from Operations | 24.09M | 16.21M | 19.35M | 9.30M | 21.27M |
| Capital Expenditure | -18.87M | -15.32M | -11.10M | -13.81M | -13.14M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 5.35M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2.42M | -1.49M | -6.09M | -7.21M | 759.00K |
| Cash from Investing | -16.45M | -16.81M | -17.18M | -21.01M | -7.03M |
| Total Debt Issued | 84.41M | 73.00M | 62.00M | 86.00M | 60.53M |
| Total Debt Repaid | -80.59M | -70.43M | -76.12M | -64.80M | -63.43M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -4.87M | -4.87M | -4.86M | -4.86M | -4.86M |
| Other Financing Activities | -567.00K | -- | -- | -- | 0.00 |
| Cash from Financing | -1.62M | -2.30M | -18.98M | 16.34M | -7.77M |
| Foreign Exchange rate Adjustments | 462.00K | 2.34M | -471.00K | 107.00K | 1.21M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 6.49M | -557.00K | -17.28M | 4.73M | 7.69M |